Global CRISPR Technology Market Size & Trends Report Segmented by Offering (Products, Kits & Enzymes, Libraries, Services), Application (Biomedical, Agricultural), End User (Pharmaceutical & Biotechnology Companies; Research Institutes) & Regional Forecast to 2030
The global CRISPR technology market is expected to witness a growth rate of 16% in the next five years. Continuous advancements in CRISPR technology; rising demand for precise and efficient gene-editing tools and therapies; growing prevalence of genetic disorders; significant investments from governments, private companies, and venture capitalists; collaborations between academic institutions, biotechnology companies, and pharmaceutical firms; and integration with other technologies like artificial intelligence (AI) and nanotechnology are some of the key factors driving the CRISPR technology market growth. To learn more about the research report, download a sample report.
Report Overview
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) is a revolutionary gene-editing technology derived from bacterial defense mechanisms. It uses the Cas9 (or other Cas proteins) enzyme to precisely cut DNA at targeted locations, allowing for gene modification, deletion, or replacement. CRISPR has transformed genetic research, enabling advancements in medicine, agriculture, and biotechnology. It holds promise for treating genetic disorders, developing disease-resistant crops, and advancing synthetic biology. However, challenges like ethical concerns, off-target effects, and regulatory hurdles remain. Despite these, CRISPR continues to drive innovation in gene therapy, drug discovery, and personalized medicine, shaping the future of biotechnology. 
To learn more about this report, download the PDF brochure
Growing Investments from Governments, Private Companies, and Venture Capitalists to Drive Market Growth
In recent years, fundings and investments in CRISPR technology have been significant, showcasing the growing interest and support for this innovative field. In February 2024, CRISPR Therapeutics secured approximately USD 280 million through an agreement to sell its common shares to a select group of institutional investors. This investment aims to accelerate their gene-editing programs and expand their therapeutic pipeline. Another notable example is the Indian biotechnology start-up CrisprBits, which raised USD 250,000 in pre-seed funding from US-based VJ Group in February 2023. This funding is intended for developing CRISPR-based diagnostics to detect pathogens and antimicrobial resistance genes. Likewise, in July 2023, Pfizer Inc. made a USD 25 million equity investment in Caribou Biosciences, Inc. a leading clinical-stage CRISPR genome-editing biopharmaceutical company. These examples highlight the substantial financial support and confidence in the potential of CRISPR technology. 
To learn more about this report, download the PDF brochure
Precision and Efficiency Associated with CRISPR Technology to Fuel Market Growth
Advancements in imaging technology are a major driver of the CRISPR technology market. Innovations such as CRISPR has become the most widely used gene-editing tool in medicine, agriculture, and microbiology due to its precision and efficiency. The growing demand for accurate gene-editing solutions drives market expansion. CRISPR enables targeted DNA modifications with minimal off-target effects, making it ideal for gene therapies. It outperforms other tools in success rates, enhancing its appeal to researchers and developers. Its applications span gene knockouts, insertions, corrections, and regulation in drug discovery, agriculture, and diagnostics. Continuous R&D has improved CRISPR’s specificity and expanded its applications, further fueling its adoption and market growth in gene-editing technologies.
Competitive Landscape Analysis
The global CRISPR technology market is marked by the presence of established and emerging market players such as Thermo Fisher Scientific, Inc., Merck KGaA, Agilent Technologies, Inc., CRISPR Therapeutics AG, Genscript Biotech Corporation, Lonza Group, Ltd., PerkinElmer, Inc., Caribou Biosciences, Inc., Hera Biolabs, and Editas Medicine; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Scope | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 - 2024 |
| Forecast Period | 2025 - 2030 |
| Growth Rate | 16% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Offering, Application, End User |
| Regional Scope |
|
| Key Companies Mapped | Thermo Fisher Scientific, Inc., Merck KGaA, Agilent Technologies, Inc., CRISPR Therapeutics AG, Genscript Biotech Corporation, Lonza Group, Ltd., PerkinElmer, Inc., Caribou Biosciences, Inc., Hera Biolabs, and Editas Medicine; among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Market Segmentation
This report by Medi-Tech Insights provides the size of the global CRISPR technology market at the regional- and country-level from 2023 to 2030. The report further segments the market based on offering, application, end user.
- Market Size & Forecast (2023-2030), By Offering, USD Million
- Products
- CRISPR Kits & Enzymes
- CRISPR Libraries
- Other Products
- Services
- Cell Line Engineering
- gRNA Synthesis
- Screening and Validation
- Other Services
- Products
- Market Size & Forecast (2023-2030), By Application, USD Million
- Biomedical Applications
- Agricultural Applications
- Other Applications
- Market Size & Forecast (2023-2030), By End User, USD Million
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Other End Users
- Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
- North America
Key Strategic Questions Addressed
- What is the market size & forecast of the CRISPR technology market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the CRISPR technology market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- CRISPR Technology Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Continuous advancements in CRISPR technology
- Rising demand for precise and efficient gene-editing tools and therapies
- Growing prevalence of genetic disorders
- Significant investments from governments, private companies, and venture capitalists
- Collaborations between academic institutions, biotechnology companies, & pharmaceutical firms
- Integration with other technologies like artificial intelligence (AI) and nanotechnology
- Restraints
- Ethical and regulatory concerns
- Technical limitations
- Cost and accessibility
- Opportunities
- Rising adoption of CRISPR in drug discovery and precision medicine
- Expanding CRISPR’s application in gene and cell therapies
- Application in agriculture and industrial biotechnology
- Drivers
- Key Market Trends
- Advancements in CRISPR-based gene therapies
- Development of next-generation CRISPR systems
- Unmet Market Needs
- Industry Speaks
- Market Dynamics
- Global CRISPR Technology Market Size & Forecast (2023-2030), By Offering, USD Million
- Introduction
- Products
- CRISPR Kits & Enzymes
- CRISPR Libraries
- Other Products
- Services
- Cell Line Engineering
- gRNA Synthesis
- Screening and Validation
- Other Services
- Global CRISPR Technology Market Size & Forecast (2023-2030), By Application, USD Million
- Introduction
- Biomedical Applications
- Agricultural Applications
- Other Applications
- Global CRISPR Technology Market Size & Forecast (2023-2030), By End User, USD Million
- Introduction
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Other End Users
- Global CRISPR Technology Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction
- North America CRISPR Technology Market Size & Forecast (2023-2030), By Country, USD Million
- US
- Market Size & Forecast, By Offering (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Canada
- Market Size & Forecast, By Offering (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- US
- Europe CRISPR Technology Market Size & Forecast (2023-2030), By Country, USD Million
- UK
- Market Size & Forecast, By Offering (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Germany
- Market Size & Forecast, By Offering (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- France
- Market Size & Forecast, By Offering (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Italy
- Market Size & Forecast, By Offering (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Spain
- Market Size & Forecast, By Offering (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Europe
- Market Size & Forecast, By Offering (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- UK
- Asia Pacific (APAC) CRISPR Technology Market Size & Forecast (2023-2030), By Country, USD Million
- China
- Market Size & Forecast, By Offering (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Japan
- Market Size & Forecast, By Offering (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- India
- Market Size & Forecast, By Offering (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Offering (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- China
- Latin America (LATAM) CRISPR Technology Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Offering (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Middle East & Africa (MEA) CRISPR Technology Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Offering (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2025)
- New Product and Service Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Company Profiles*(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Agilent Technologies, Inc.
- CRISPR Therapeutics AG
- Genscript Biotech Corporation
- Lonza Group, Ltd.
- PerkinElmer, Inc.
- Caribou Biosciences, Inc.
- Hera Biolabs
- Editas Medicine
- Other Prominent Players
Note: *Indicative list
**For listed companies
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Stakeholders in Pharmaceutical and Biotechnology Companies, Academic and Government Research Institutes, Contract Research Organizations (CROs) and Other End Users
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down and Bottom-Up Approaches’ were used to derive market size estimates and forecasts.
Data Triangulation
Research findings derived through secondary sources & internal analysis were validated with Primary Interviews, Internal Knowledge Repository, and Company Sales Data.
